Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Tolerance of Anti-Cancer Therapy in the Elderly
Authors not listed
The Leeds Teaching Hospitals NHS Trust · 2020
Abstract
This is a multicentre observational study evaluating frailty and tolerance of chemotherapy in the elderly.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2020). Tolerance of Anti-Cancer Therapy in the Elderly. <em>The Leeds Teaching Hospitals NHS Trust</em>. https://clinicaltrials.gov/study/NCT05251922
Vancouver
Anonymous. Tolerance of Anti-Cancer Therapy in the Elderly. The Leeds Teaching Hospitals NHS Trust. 2020.
BibTeX
@misc{anon2020Tolera,
title = {Tolerance of Anti-Cancer Therapy in the Elderly},
author = {Anonymous},
journal = {The Leeds Teaching Hospitals NHS Trust},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2020
Citation only
Frailty Assessment
Universitaire Ziekenhuizen KU Leuven 2009
Open access · US-GOV
Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients.
The University of Texas Health Science Center at San Antonio 2012
Open access · US-GOV
A Pilot Trial of Frailty Assessment in Older Adults (Age 70 >) Requiring Concurrent Chemotherapy Plus Radiation Therapy for Cancer (CTRC# 12-22)
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Wake Forest University Health Sciences 2010
Open access · US-GOV
A Phase II Study of Fraility Index and Geriatric Assessment as Predictors of Toxicity to Front-Line Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer
Cochlear 2017
Open access · US-GOV